These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 28537967

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes in morphine reward in a model of neuropathic pain.
    Cahill CM, Xue L, Grenier P, Magnussen C, Lecour S, Olmstead MC.
    Behav Pharmacol; 2013 Jun; 24(3):207-13. PubMed ID: 23591124
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Upregulation of tumor necrosis factor-alpha in nucleus accumbens attenuates morphine-induced rewarding in a neuropathic pain model.
    Wu Y, Na X, Zang Y, Cui Y, Xin W, Pang R, Zhou L, Wei X, Li Y, Liu X.
    Biochem Biophys Res Commun; 2014 Jul 11; 449(4):502-7. PubMed ID: 24845379
    [Abstract] [Full Text] [Related]

  • 5. A functional polymorphism in the ATP-Binding Cassette B1 transporter predicts pharmacologic response to combination of nortriptyline and morphine in neuropathic pain patients.
    Benavides R, Vsevolozhskaya O, Cattaneo S, Zaykin D, Brenton A, Parisien M, Verma V, Khoury S, Gilron I, Diatchenko L.
    Pain; 2020 Mar 11; 161(3):619-629. PubMed ID: 31738228
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Behavioral effects of combined morphine and MK-801 administration to the locus coeruleus of a rat neuropathic pain model.
    Llorca-Torralba M, Mico JA, Berrocoso E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun 08; 84(Pt A):257-266. PubMed ID: 29524514
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Persistent Nociception Facilitates the Extinction of Morphine-Induced Conditioned Place Preference.
    You Z, Ding W, Doheny JT, Yang J, Yang L, Lim G, Miao J, Chen L, Shen S, Mao J.
    Anesth Analg; 2019 Sep 08; 129(3):890-895. PubMed ID: 31425234
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes of CREB in rat hippocampus, prefrontal cortex and nucleus accumbens during three phases of morphine induced conditioned place preference in rats.
    Zhou LF, Zhu YP.
    J Zhejiang Univ Sci B; 2006 Feb 08; 7(2):107-13. PubMed ID: 16421965
    [Abstract] [Full Text] [Related]

  • 12. Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine.
    Pilat D, Piotrowska A, Rojewska E, Jurga A, Ślusarczyk J, Makuch W, Basta-Kaim A, Przewlocka B, Mika J.
    Mol Cell Neurosci; 2016 Mar 08; 71():114-24. PubMed ID: 26763728
    [Abstract] [Full Text] [Related]

  • 13. Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens.
    Ventura R, Alcaro A, Puglisi-Allegra S.
    Cereb Cortex; 2005 Dec 08; 15(12):1877-86. PubMed ID: 15728739
    [Abstract] [Full Text] [Related]

  • 14. Opioid Activity in the Locus Coeruleus Is Modulated by Chronic Neuropathic Pain.
    Llorca-Torralba M, Pilar-Cuéllar F, Bravo L, Bruzos-Cidon C, Torrecilla M, Mico JA, Ugedo L, Garro-Martínez E, Berrocoso E.
    Mol Neurobiol; 2019 Jun 08; 56(6):4135-4150. PubMed ID: 30284123
    [Abstract] [Full Text] [Related]

  • 15. Endogenous histamine inhibits the development of morphine-induced conditioned place preference.
    Gong YX, Lv M, Zhu YP, Zhu YY, Wei EQ, Shi H, Zeng QL, Chen Z.
    Acta Pharmacol Sin; 2007 Jan 08; 28(1):10-8. PubMed ID: 17184577
    [Abstract] [Full Text] [Related]

  • 16. Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex.
    Navratilova E, Nation K, Remeniuk B, Neugebauer V, Bannister K, Dickenson AH, Porreca F.
    Pain; 2020 Mar 08; 161(3):609-618. PubMed ID: 31725062
    [Abstract] [Full Text] [Related]

  • 17. The oxytocin analogue carbetocin prevents priming-induced reinstatement of morphine-seeking: Involvement of dopaminergic, noradrenergic and MOPr systems.
    Georgiou P, Zanos P, Garcia-Carmona JA, Hourani S, Kitchen I, Kieffer BL, Laorden ML, Bailey A.
    Eur Neuropsychopharmacol; 2015 Dec 08; 25(12):2459-64. PubMed ID: 26475574
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D1 and D3 receptor modulators restore morphine analgesia and prevent opioid preference in a model of neuropathic pain.
    Rodgers HM, Yow J, Evans E, Clemens S, Brewer KL.
    Neuroscience; 2019 May 15; 406():376-388. PubMed ID: 30910641
    [Abstract] [Full Text] [Related]

  • 19. Glial cell line-derived neurotrophic factor-mediated enhancement of noradrenergic descending inhibition in the locus coeruleus exerts prolonged analgesia in neuropathic pain.
    Kimura M, Sakai A, Sakamoto A, Suzuki H.
    Br J Pharmacol; 2015 May 15; 172(10):2469-78. PubMed ID: 25572945
    [Abstract] [Full Text] [Related]

  • 20. Oxytocin enhances the expression of morphine-induced conditioned place preference in rats.
    Moaddab M, Hyland BI, Brown CH.
    Psychoneuroendocrinology; 2015 Mar 15; 53():159-69. PubMed ID: 25618594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.